Assessment of Oxycodone and Mebeverin mixed-effects on colonoscopy quality
Phase 3
- Conditions
- colonoscopy.Gastrointestinal hemorrhage, unspecifiedK92.2
- Registration Number
- IRCT20201204049599N3
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 125
Inclusion Criteria
Age over 18 years
Do not take antispasmodics
Suspicion of intestinal polyps
bowel diseases
Unknown gastrointestinal bleeding
Exclusion Criteria
Irritable Bowel Syndrome
Previous abdominal surgeries
Lack of mental health and full consciousness
Allergy to oxycodone
Allergy to Mebeverine
Taking anti-anxiety and painkillers
History of allergy to any drug
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total procedure time. Timepoint: During endoscopy. Method of measurement: minute, clock.;Pain. Timepoint: During endoscopy. Method of measurement: Score based on visual analog scale.;Time to reach Cecum. Timepoint: During endoscopy. Method of measurement: minute , clock.
- Secondary Outcome Measures
Name Time Method